News Features Roughly 80% of ESC Guideline Writers Have Financial COIs Michael O'Riordan April 01, 2021
News Conference News EHRA 2019 Thromboembolic Risks High in Patients With A-fib, Valvular Disease Todd Neale March 25, 2019
News Opinion Conversations in Cardiology Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC? November 16, 2018
News Conference News ESC 2017 European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts Shelley Wood August 27, 2017
News Daily News Focused Update to Valve Guidelines Tackles Intermediate-Risk TAVR, Anticoagulation for A-fib Todd Neale March 15, 2017
News Industry News NICE recommends once-daily LIXIANA® (edoxaban) for the treatment and prevention of recurrent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in adults July 13, 2015